Cardiac Imaging

A comprehensive strategy involving shared cardiac PET scans was associated with better CV outcomes compared with standard care in patients with suspected CAD, according to the results of the CENTURY trial.

Data suggest that left atrial scarring observed with 2D long-axis MRI is associated with adverse atrial remodeling and incident clinically detected atrial fibrillation, researchers reported.

New data presented at the European Society of Cardiology Congress indicate that use of intravascular imaging during PCI improves clinical outcomes, but the issue of adoption is complicated.

The use of intravascular imaging — OCT or IVUS — during PCI appears to reduce complications and produce overall better clinical outcomes than using angiography guidance, according to three studies and a meta-analysis.

Appropriate use criteria that have been certified by CMS for coronary artery disease imaging are heterogeneous and, at times, discrepant, according to a review recently published in Annals of Internal Medicine.

Biosense Webster announced several of its products in its cardiac ablation portfolio have received FDA approval for use without fluoroscopy.

UltraSight announced it received FDA 510(k) clearance for its AI-guided ultrasound technology designed to assist providers without sonography experience acquiring point-of-care cardiac ultrasound images.

ARLINGTON, Texas — In this Healio video exclusive, Fatima Rodriguez, MD, MPH, discusses the use of artificial intelligence to quantify coronary artery calcium from CT scans done for non-CV reasons.

Biotronik announced the FDA approved its portfolio of pacemakers and cardiac resynchronization therapy pacemakers featuring automatic MRI detection designed to streamline MRI workflow.

Researchers in Brazil identified new echocardiographic parameters and biomarkers prognostic of poor cardiac event-free survival among patients with chronic Chagas disease, which affects up to 7 million worldwide.